OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
# OpenAI acquires startup Orchestra Bio to beef up its biotech business | TechCrunch
Source: [https://techcrunch.com/2026/10/20/openai-acquires-startup-orchestra-bio%E2%81%A0-to-beef-up-its-biotech-business/](https://techcrunch.com/2026/10/20/openai-acquires-startup-orchestra-bio%E2%81%A0-to-beef-up-its-biotech-business/)
In Brief
Posted:
1:35 PM PDT · October 20, 2026
**Image Credits:**[FotografiaBasica\(opens in a new window\)](https://www.gettyimages.com/search/2/image?artistexact=FotografiaBasica)/ Getty ImagesOpenAI on Tuesday acquired a four\-year\-old AI biotech software startup called Orchestra Bio, the company[announced](https://openai.com/index/openai-to-acquire-orchestra-bio/)on its website\. Terms of the deal were not disclosed, but the startup had reportedly raised[around $20 million](https://www.biotechtv.com/post/after-exiting-stealth-with-20-million-two-weeks-ago-orchestra-bio-is-out-to-help-science-entrepren)as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC\.
Orchestra creates AI agents that help biotech companies manage the minutiae of drug\-discovery operations, from tracking finances to resolving scheduling issues with clinical trials\.
OpenAI says it’s adding Orchestra’s team and technology to work on[Rosalind](https://openai.com/rosalind/), its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results\. OpenAI has already won some big names as customers for Rosalind, including, it says,[Moderna](https://openai.com/rosalind/#moderna)and[Novo Nordisk\.](https://openai.com/rosalind/#novo-nordisk)
The acquisition is a classic example of how the biggest AI labs \(namely OpenAI and Anthropic\) are building ever more software for the biggest industries, like pharma\. In the startup world, there is an ongoing fear that at any moment, the labs will launch new features and become competitors\. In this case, Orchestra is getting absorbed, rather than stomped out\.
### Newsletters
Subscribe for the industry’s biggest tech news
## Related
## Latest in AI
OpenAI has acquired Orchestra Bio, a platform for coordinating drug development workflows, and will integrate it with Rosalind, its AI models and tools for life sciences research, aiming to build AI agents that help biopharma teams advance medicines faster.
OpenAI announces Rosalind Biodefense, a program to provide trusted developers and U.S. government partners with advanced AI tools for biodefense and pandemic preparedness, building on earlier GPT-Rosalind capabilities and safety frameworks.
OpenAI launches Rosalind Workbench, a virtual environment that integrates AI models and scientific tools to help life science researchers streamline data analysis, explore biological questions, and accelerate workflows.
OpenAI's deployment arm acquires Northslope, an applied-AI firm, to embed engineers directly in customer businesses, mirroring Palantir's model to boost enterprise AI adoption.
OpenAI acquires Rockset, a real-time analytics database company, to integrate its data indexing and querying capabilities into OpenAI's retrieval infrastructure and AI products.